新华财经上海4月28日电(林郑宏)A股CRO(医药外包)行业龙头药明康德4月28日发布2025年一季报,显示当季实现营业收入96.55亿元,同比增长20.96%;归属于上市公司股东的净利润36.72亿元,同比增长89.06%;扣非净利润23.29亿元,同比增长14.50%。公司表示,报告期内公司净利大幅增长主要系公司在保持营业收入增长的同时,不断优化生产工艺和经营效率,以及临床后期和商业化项目增长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.